CytoDyn (CYDY) Shares Issued (2011 - 2026)

CytoDyn's Shares Issued history runs 14 years deep, the most recent figure standing at $31.3 million for Q1 2026.

• Quarterly Shares Issued fell 16.19% year-over-year to $31.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $31.3 million (down 16.19% YoY) and the FY2025 annual result came in at $38.3 million, up 48.26% from the prior year.
• Shares Issued was $31.3 million for Q1 2026 at CytoDyn, down from $38.5 million in the prior quarter.
• Across five years, Shares Issued topped out at $38.5 million in Q3 2025 and bottomed at $10.3 million in Q1 2022.
• A 5-year average of $25.9 million and a median of $24.4 million in 2024 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2023 — Shares Issued tumbled 39.82% — and 2024, when it surged 164.14%.
• CytoDyn's Shares Issued stood at $22.0 million in 2022, then plunged by 35.51% to $14.2 million in 2023, then soared by 164.14% to $37.5 million in 2024, then rose by 2.66% to $38.5 million in 2025, then slipped by 18.58% to $31.3 million in 2026.
• Business Quant data shows CYDY's Shares Issued at $31.3 million in Q1 2026, $38.5 million in Q4 2025, and $38.5 million in Q3 2025.